Terry Smith: portfolio of Fundsmith LLP
Terry Smith leads the British fund manager Fundsmith, which holds a concentrated portfolio of large companies for the long term.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 17, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2025. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 17.1B USD
- Positions
- 37
- Share of the ten largest
- 66.9%
The ten largest positions Q4 2025
- Waters Corporation 7.9%▼ −10.0%
- Stryker Corporation 7.6%▼ −19.7%
- Idexx Laboratories 7.4%▼ −28.1%
- Visa Inc. 7.2%▼ −8.3%
- Marriott International 7.2%▼ −5.9%
- Alphabet Inc. (Class A) 6.4%▼ −44.4%
- Automatic Data Processing 6.3%▼ −3.1%
- Microsoft 5.9%▼ −19.5%
- Philip Morris International 5.7%▼ −14.8%
- Meta Platforms 5.3%▼ −12.5%
Show all positions of this quarter
Choose a quarter (55 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
- Q1 2013
All positions Q4 2025
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Nutanix Inc | 0.4% | 1,377,158 | 71.2M USD | new | Q4 2025 1 quarter |
| Adma Biologics Inc | 0.2% | 2,102,054 | 38.3M USD | new | Q4 2025 1 quarter |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Health Care 30.5%
- Technology 14.4%
- Consumer Staples 13.0%
- Communication Services 11.7%
- Consumer Discretionary 9.5%
- Industrials 8.8%
- Financials 7.8%
- not in our coverage 4.4%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors